The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors Stanford University -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Links ClinicalTrials.gov
Determine whether peanut oral immunotherapy (OIT) induces clinical tolerance as assessed after the initial 3 month avoidance period Secondary Objectives: * Identify the basic immune mechanisms which can explain the differences in the effects of OIT in desensitized vs. tolerant individuals. * Determine whether immune monitoring measurements reflecting underlying mechanisms during OIT can be used to predict responses to OIT in individual subjects and, ultimately, to improve the safety and efficacy outcomes in peanut OIT protocols.
Epistemonikos ID: 0260d7730c0e653a495c7fda20ac1449065f7553
First added on: May 11, 2024